8296.HK
Sino-Life Group Limited [8296.HK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
8296.HK Stock Summary
Top 10 Correlated ETFs
8296.HK
Top 10 Correlated Stocks
8296.HK
In the News
8296.HK Financial details
Company Rating
Buy
Market Cap
75.23M
Income
-925K
Revenue
76.18M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
218
Optionable
No
Shortable
Yes
Earnings
08 Nov 2023
P/E
-70.85
Forward P/E
-
PEG
7.4
P/S
0.93
P/B
0.59
P/C
-
P/FCF
-
Quick Ratio
1.62
Current Ratio
1.67
Debt / Equity
-
LT Debt / Equity
0.15
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-103.36%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
4.47%
Revenue Q/Q
-6.55%
EPS Q/Q
-62.34%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-1%
ROC
-
Gross Margin
42%
Oper. Margin
-
Profit Margin
-1%
Payout
-
Shs Outstand
885M
Shs Float
467.87M
-
-
-
-
Target Price
-
52W Range
0.076-0.199
52W High
-
52W Low
-
RSI
40
Rel Volume
5.03
Avg Volume
66.03K
Volume
332K
Perf Week
-8.42%
Perf Month
-9.38%
Perf Quarter
-37.86%
Perf Half Y
-37.86%
-
-
-
-
Beta
0.358
-
-
Volatility
0%, 0%
Prev Close
-4.4%
Price
0.087
Change
-4.4%
8296.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.08 | 0.09 | 0.09 | 0.1 | 0.11 | |
| Net income per share | -0.01 | -0.01 | 0 | -0.02 | 0 | |
| Operating cash flow per share | 0.01 | 0.01 | 0.02 | 0 | 0.01 | |
| Free cash flow per share | 0 | 0.01 | 0.02 | -0.01 | 0.01 | |
| Cash per share | 0.18 | 0.21 | 0.21 | 0.21 | 0.24 | |
| Book value per share | 0.14 | 0.17 | 0.16 | 0.15 | 0.15 | |
| Tangible book value per share | 0.13 | 0.16 | 0.15 | 0.14 | 0.17 | |
| Share holders equity per share | 0.14 | 0.17 | 0.16 | 0.15 | 0.15 | |
| Interest debt per share | 0.01 | 0.06 | 0.06 | 0.05 | 0.04 | |
| Market cap | 155.17M | 89.4M | 100.46M | 107.87M | 107.46M | |
| Enterprise value | 61.01M | 13.44M | 15.62M | 23.8M | 22.89M | |
| P/E ratio | -18.58 | -21.47 | -51.73 | -6.1 | 171.66 | |
| Price to sales ratio | 2.48 | 1.34 | 1.47 | 1.48 | 1.38 | |
| POCF ratio | 31.1 | 15.09 | 5.62 | -265.03 | 10.49 | |
| PFCF ratio | 45.04 | 17.3 | 7.09 | -25.03 | 13.83 | |
| P/B Ratio | 1.47 | 0.71 | 0.84 | 0.94 | 0.95 | |
| PTB ratio | 1.47 | 0.71 | 0.84 | 0.94 | 0.95 | |
| EV to sales | 0.97 | 0.2 | 0.23 | 0.33 | 0.29 | |
| Enterprise value over EBITDA | -14.27 | 3.07 | 1.25 | 2.44 | 1.51 | |
| EV to operating cash flow | 12.23 | 2.27 | 0.87 | -58.48 | 2.23 | |
| EV to free cash flow | 17.71 | 2.6 | 1.1 | -5.52 | 2.95 | |
| Earnings yield | -0.05 | -0.05 | -0.02 | -0.16 | 0.01 | |
| Free cash flow yield | 0.02 | 0.06 | 0.14 | -0.04 | 0.07 | |
| Debt to equity | 0.09 | 0.34 | 0.33 | 0.29 | 0.25 | |
| Debt to assets | 0.04 | 0.15 | 0.14 | 0.13 | 0.1 | |
| Net debt to EBITDA | 22.03 | -17.33 | -6.81 | -8.61 | -5.57 | |
| Current ratio | 1.54 | 1.58 | 1.59 | 1.48 | 1.73 | |
| Interest coverage | -25.58 | -0.85 | 0.8 | 0.66 | 3.85 | |
| Income quality | -0.67 | -2.02 | 12.1 | 0.03 | 1.3 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.4 | 0.42 | 0.36 | 0.49 | 0.41 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0 | 0 | 0.01 | 0 | |
| Capex to operating cash flow | -0.31 | -0.13 | -0.21 | 9.59 | -0.24 | |
| Capex to revenue | -0.02 | -0.01 | -0.05 | -0.05 | -0.03 | |
| Capex to depreciation | -0.54 | -0.11 | -0.36 | -0.47 | -0.31 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0.02 | |
| Graham number | 0.19 | 0.15 | 0.1 | 0.29 | 0.05 | |
| ROIC | -0.07 | -0.02 | -0.01 | 0.01 | 0 | |
| Return on tangible assets | -0.04 | -0.01 | -0.01 | -0.07 | 0 | |
| Graham Net | 0.06 | 0.03 | 0.03 | 0.03 | 0.07 | |
| Working capital | 67.97M | 79.58M | 76.49M | 62.8M | 92.97M | |
| Tangible asset value | 100.07M | 117.65M | 111.72M | 103.56M | 129.66M | |
| Net current asset value | 59.74M | 41.08M | 41.33M | 34.71M | 67.11M | |
| Invested capital | 0.09 | 0.34 | 0.33 | 0.29 | 0.25 | |
| Average receivables | 46.56M | 51.55M | 48.3M | 37.25M | 32.45M | |
| Average payables | 2.13M | 3.01M | 2.62M | 2.22M | 7.6M | |
| Average inventory | 1.1M | 1.03M | 1.26M | 1.59M | 1.62M | |
| Days sales outstanding | 293.04 | 289.21 | 234.04 | 153.72 | 160.17 | |
| Days payables outstanding | 31.42 | 31.94 | 20.66 | 23.24 | 124.04 | |
| Days of inventory on hand | 11.39 | 10.2 | 14.41 | 17 | 15.46 | |
| Receivables turnover | 1.25 | 1.26 | 1.56 | 2.37 | 2.28 | |
| Payables turnover | 11.62 | 11.43 | 17.67 | 15.71 | 2.94 | |
| Inventory turnover | 32.05 | 35.78 | 25.34 | 21.47 | 23.6 | |
| ROE | -0.08 | -0.03 | -0.02 | -0.15 | 0.01 | |
| Capex per share | 0 | 0 | -0.01 | -0.01 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | |
| Net income per share | 0 | 0.01 | 0 | -0.01 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0.24 | 0 | 0.25 | 0 | |
| Book value per share | 0 | 0.15 | 0 | 0.15 | 0 | |
| Tangible book value per share | 0 | 0.17 | 0 | 0.17 | 0 | |
| Share holders equity per share | 0 | 0.15 | 0 | 0.15 | 0 | |
| Interest debt per share | 0 | 0.04 | 0 | 0.03 | 0 | |
| Market cap | 96.23M | 107.46M | 97.37M | 96.06M | 81.76M | |
| Enterprise value | 0 | 22.89M | 0 | 953.23K | 0 | |
| P/E ratio | 14.15 | 5.17 | 12.44 | -4.18 | -8.75 | |
| Price to sales ratio | 4.81 | 5.17 | 3.85 | 6.17 | 5.62 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0 | 0.95 | 0 | 0.86 | 0 | |
| PTB ratio | 0 | 0.95 | 0 | 0.86 | 0 | |
| EV to sales | 0 | 1.1 | 0 | 0.06 | 0 | |
| Enterprise value over EBITDA | 0 | 5.85 | 0 | -0.2 | 0 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0.02 | 0.05 | 0.02 | -0.06 | -0.03 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0.25 | 0 | 0.23 | 0 | |
| Debt to assets | 0 | 0.1 | 0 | 0.09 | 0 | |
| Net debt to EBITDA | 0 | -21.62 | 0 | 20.08 | 0 | |
| Current ratio | 0 | 1.73 | 0 | 1.67 | 0 | |
| Interest coverage | 8.81 | 14.89 | 6.26 | -13.66 | -10.38 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.28 | 0.34 | 0.29 | 0.83 | 0.32 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0.16 | 0 | 0.16 | 0 | |
| ROIC | 0 | 0.03 | 0 | -0.04 | 0 | |
| Return on tangible assets | 0 | 0.02 | 0 | -0.02 | 0 | |
| Graham Net | 0 | 0.07 | 0 | 0.07 | 0 | |
| Working capital | 0 | 92.97M | 0 | 87.65M | 0 | |
| Tangible asset value | 0 | 129.66M | 0 | 128.18M | 0 | |
| Net current asset value | 0 | 67.11M | 0 | 65.71M | 0 | |
| Invested capital | 0 | 0.25 | 0 | 0.23 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 148.06 | 0 | 155.08 | 0 | |
| Days payables outstanding | 0 | 95.34 | 0 | 27.96 | 0 | |
| Days of inventory on hand | 0 | 11.88 | 0 | 20.86 | 0 | |
| Receivables turnover | 0 | 0.61 | 0 | 0.58 | 0 | |
| Payables turnover | 0 | 0.94 | 0 | 3.22 | 0 | |
| Inventory turnover | 0 | 7.57 | 0 | 4.31 | 0 | |
| ROE | 0 | 0.05 | 0 | -0.05 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
8296.HK Frequently Asked Questions
What is Sino-Life Group Limited stock symbol ?
Sino-Life Group Limited is a HK stock and trading under the symbol 8296.HK
What is Sino-Life Group Limited stock quote today ?
Sino-Life Group Limited stock price is $0.087 today.
Is Sino-Life Group Limited stock public?
Yes, Sino-Life Group Limited is a publicly traded company.
Company Profile
- Volume Average 66.03K
- Market Capitalization 75.23M
- Employee 218
- CEO Mr. Tien-Tsai Liu
- Headquarters Sheung Wan,HK
- IPO Date 2009-09-09
-
Website
https://www.sinolifegroup.com 
Sino-Life Group Limited, an investment holding company, provides funeral services in the People's Republic of China, Taiwan, Hong Kong, and Vietnam. It operates through the segments Funeral Services; and Stem Cells and Immunocytes and Other Business. The company offers funeral arrangement services to funeral and non-funeral services deed holders; and cremation services in funeral parlours and funeral service centers. It also sells burial plots and tombstones; and provides cemetery maintenance services, as well as elderly care and related consultancy services. In addition, the company provides advisory service on stem cells and immunocytes; and sells biotechnical machinery. Sino-Life Group Limited was incorporated in 2005 and is based in Sheung Wan, Hong Kong.
